Speciality: Sterile Services
Location: London
Duration: Temporary
Speciality: Sterile Services
Location: London
Duration: Temporary
Speciality: Sterile Services
Location: London
Duration: Temporary
Speciality: Sterile Services
Location: London
Duration: Temporary
Cases of Clostridium difficile (C diff) are set to be targeted, as a new antibiotic has been developed to tackle the illness which has been prevalent in a number of hospital outbreaks.
The medication, known as fidaxomicin, has been approved by experts in Scotland, and becomes the first type of drug to fight C diff since the 1950s with the potential to save the lives of patients who are affected by the infection.
It has already been heralded as a major step forward in the treatment of this illness. Officials have stated, however, that it will only be administered to adults who develop a second bout of C diff.
Professor Robert Masterton, director of the Institute of Healthcare Associated Infection at the University of the West of Scotland, said: "The approval of fidaxomicin represents a notable milestone in combating the still significant impact and spread of this disease."
It comes after STV reported that a hospital in the Highlands had to close it cancer ward following the outbreak of a C diff virus.
Search for sterile services jobs at Mediplacements, a genuine specialist providing recruitment opportunities in the NHS and private sector.
written by Martin Lambert
The importance of effective sterile services has been highlighted after a safety inspection led to the closure...
An NHS Trust has said it has a "robust plan" in place to protect against any possible occurrence...
A £2.6 million extension to the endoscopy and sterile services unit at Kettering General Hospital will...
A new kind of sterile gel that can be used to treat wounds has been developed by scientists in China, offering...